127 related articles for article (PubMed ID: 1343377)
1. [Controlled study of the effect of silymarin on alcoholic liver disease].
Bunout D; Hirsch S; Petermann M; de la Maza MP; Silva G; Kelly M; Ugarte G; Iturriaga H
Rev Med Chil; 1992 Dec; 120(12):1370-5. PubMed ID: 1343377
[TBL] [Abstract][Full Text] [Related]
2. [Liver-protective action of silymarin therapy in chronic alcoholic liver diseases].
Fehér J; Deák G; Müzes G; Láng I; Niederland V; Nékám K; Kárteszi M
Orv Hetil; 1989 Dec; 130(51):2723-7. PubMed ID: 2574842
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of alcoholic hepatitis with silymarin. A double-blind comparative study in 116 patients].
Trinchet JC; Coste T; Lévy VG; Vivet F; Duchatelle V; Legendre C; Gotheil C; Beaugrand M
Gastroenterol Clin Biol; 1989; 13(2):120-4. PubMed ID: 2707520
[TBL] [Abstract][Full Text] [Related]
4. Effect of treatment with paromomycin on endotoxemia in patients with alcoholic liver disease--a double-blind, placebo-controlled trial.
Bode C; Schäfer C; Fukui H; Bode JC
Alcohol Clin Exp Res; 1997 Nov; 21(8):1367-73. PubMed ID: 9394106
[TBL] [Abstract][Full Text] [Related]
5. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
6. Long-term treatment of alcoholic liver disease with propylthiouracil.
Orrego H; Blake JE; Blendis LM; Compton KV; Israel Y
N Engl J Med; 1987 Dec; 317(23):1421-7. PubMed ID: 3317042
[TBL] [Abstract][Full Text] [Related]
7. [Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C].
Pár A; Róth E; Rumi G; Kovács Z; Nemes J; Mózsik G
Orv Hetil; 2000 Jul; 141(30):1655-9. PubMed ID: 10962902
[TBL] [Abstract][Full Text] [Related]
8. Combined therapy of silymarin and desferrioxamine in patients with beta-thalassemia major: a randomized double-blind clinical trial.
Gharagozloo M; Moayedi B; Zakerinia M; Hamidi M; Karimi M; Maracy M; Amirghofran Z
Fundam Clin Pharmacol; 2009 Jun; 23(3):359-65. PubMed ID: 19453758
[TBL] [Abstract][Full Text] [Related]
9. Effect of short-term therapy with propylthiouracil in patients with alcoholic liver disease.
Orrego H; Kalant H; Israel Y; Blake J; Medline A; Rankin JG; Armstrong A; Kapur B
Gastroenterology; 1979 Jan; 76(1):105-15. PubMed ID: 758131
[TBL] [Abstract][Full Text] [Related]
10. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
[TBL] [Abstract][Full Text] [Related]
11. [Effect of silimarin (Legalon) therapy on the antioxidant defense mechanism and lipid peroxidation in alcoholic liver disease (double blind protocol)].
Müzes G; Deák G; Láng I; Nékám K; Niederland V; Fehér J
Orv Hetil; 1990 Apr; 131(16):863-6. PubMed ID: 2345633
[TBL] [Abstract][Full Text] [Related]
12. [Immunomodulator effect of silymarin therapy in chronic alcoholic liver diseases].
Deák G; Müzes G; Láng I; Niederland V; Nékám K; Gonzalez-Cabello R; Gergely P; Fehér J
Orv Hetil; 1990 Jun; 131(24):1291-2, 1295-6. PubMed ID: 2195425
[TBL] [Abstract][Full Text] [Related]
13. [Results of a double blind study on the effect of silymarin in the treatment of acute viral hepatitis, carried out at two medical centres (author's transl)].
Magliulo E; Gagliardi B; Fiori GP
Med Klin; 1978 Jul; 73(28-29):1060-5. PubMed ID: 353464
[TBL] [Abstract][Full Text] [Related]
14. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
15. The metabolic and bone density effects of continuous combined 17-beta estradiol and noresthisterone acetate treatments in Thai postmenopausal women: a double-blind placebo-controlled trial.
Bunyavejchevin S; Limpaphayom KK
J Med Assoc Thai; 2001 Jan; 84(1):45-53. PubMed ID: 11281499
[TBL] [Abstract][Full Text] [Related]
16. [Silymarin for the treatment of acute viral hepatitis? Report of a controlled trial (author's transl)].
Bode JC; Schmidt U; Dürr HK
Med Klin; 1977 Mar; 72(12):513-8. PubMed ID: 840125
[TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
[TBL] [Abstract][Full Text] [Related]
18. II. Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease.
Lieber CS; Weiss DG; Groszmann R; Paronetto F; Schenker S;
Alcohol Clin Exp Res; 2003 Nov; 27(11):1765-72. PubMed ID: 14634492
[TBL] [Abstract][Full Text] [Related]
19. NTP Toxicology and Carcinogenesis Studies of Promethazine Hydrochloride (CAS No. 58-33-3) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Dec; 425():1-272. PubMed ID: 12616286
[TBL] [Abstract][Full Text] [Related]
20. A pilot double-blind treatment trial of memantine for alcohol dependence.
Evans SM; Levin FR; Brooks DJ; Garawi F
Alcohol Clin Exp Res; 2007 May; 31(5):775-82. PubMed ID: 17378918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
